Point-of-Care Glucose Testing Market Revenue, Demand, Trends, Competition and Future Opportunities 2034
Point-of-Care Glucose Testing Market Growth, Size, Trends Analysis - By Product - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Mar-2025 | Report ID: HLCA2583 | Pages: 1 - 255 | Formats*: |
| Category : Healthcare | |||
Point-of-Care Glucose Testing Market Introduction and Overview
According to SPER Market Research, the Global Point-of-Care Glucose Testing Market is estimated to reach USD 5.36 billion by 2034 with a CAGR of 4.39%
The report includes an in-depth analysis of the Global Point-of-Care Glucose Testing Market, including market size and trends, product mix, Applications, and supplier analysis. The expanding geriatric population, the ability of point-of-care (POC) diagnostic tests to provide immediate results, leading to better patient care, and the growing use of electronic medical records (EMRs) are significant factors driving this market. Additionally, the shortage of skilled healthcare professionals, particularly in diagnostics, is expected to further boost the adoption of glucose POC diagnostic products. Rising awareness of diabetes management, limited access to healthcare, the scarcity of healthcare workers, and the highest prevalence of diabetes recorded in Asian countries are likely to increase the use of POC glucose testing solutions. This, in turn, presents an opportunity to alleviate the healthcare burden by improving patient outcomes. However, Point-of-care diagnostic commercialization faces hurdles due to stringent regulatory approvals and standardization challenges with lab methods. These issues lead to delayed market entry, high costs, and potential errors due to non-professional testing, hindering widespread adoption.
By Product: In 2024, the "Other Products" segment accounted for the largest share, contributing over 54.8% of the global revenue, and is expected to continue growing at a steady compound annual growth rate (CAGR) throughout the forecast period. Point-of-care (POC) monitoring devices facilitate home-based blood glucose self-monitoring, helping patients manage daily activities more easily. These devices are also used in inpatient settings due to their ease of use and quick results. Several glucose meters have been introduced to meet the growing demand for diabetes monitoring solutions in hospitals, clinics, and other healthcare environments. The Accu-Chek Inform II segment held the second-largest market share in 2024. Meanwhile, the FreeStyle Lite product segment is anticipated to experience the fastest growth during the forecast period. Offered by Abbott, the FreeStyle Lite is a compact, user-friendly device with an integrated portlight and backlight, making it ideal for patients with busy lifestyles. It is designed to measure blood sugar levels from finger, forearm, hand, upper arm, and thigh samples. The use of FreeStyle Lite is recommended with FreeStyle control solution and test strips only, as using other solutions and strips may lead to inaccurate results.
By Regional Insights: North America led the global market in 2024 and is expected to maintain its dominance throughout the forecast period. The region is home to several major market players, including Abbott, Nova Biomedical, and Prodigy Diabetes Care, LLC, which has boosted the availability of glucose testing products and contributed to the market's revenue growth. Additionally, increased government healthcare spending on diabetes management has played a key role in driving the region's market expansion.
Market Competitive Landscape:
The market is moderately consolidated. Some of the market key players are Bayer AG/Ascensia Diabetes Care Holdings AG, EKF Diagnostics, F. Hoffmann-La Roche Ltd., Nipro, Nova Biomedical, PlatInium Equity Advisors, LLC (Lifescan, Inc.), Prodigy Diabetes Care, LLC, and Trividia Health, Inc.
Recent Developments:
- In June 2024, F. Hoffmann-La Roche Ltd (Switzerland) acquired LumiraDxs (US) Point of Care technology to strengthen its capabilities in decentralized patient care. This acquisition aims to expand Roches offerings, facilitating broader global access to quick, actionable diagnostic results and improving patient outcomes. Through this strategic move, Roche seeks to further enhance its presence in the growing market for timely diagnostics and drive innovation in accessible healthcare solutions.
- In bioMerieuxs BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel Mini received FDA clearance and CLIA waiver in June 2024.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product. |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa. |
| Companies Covered | Abbott, Bayer AG/Ascensia Diabetes Care Holdings AG, EKF Diagnostics, F. Hoffmann-La Roche Ltd., Nipro, Nova Biomedical, PlatInium Equity Advisors, LLC (Lifescan, Inc.), Prodigy Diabetes Care, LLC, and Trividia Health, Inc. and others. |
Key Topics Covered in the Report:
- Global Point-of-Care Glucose Testing Market Size (FY’2021-FY’2034)
- Overview of Global Point-of-Care Glucose Testing Market
- Segmentation of Global Point-of-Care Glucose Testing Market By Product (Accu Check Aviva Meter, Onetouch Verio Flex, i-STAT, Bayer CONTOUR Blood Glucose Monitoring System, Freestyle Lite, True Metrix, Accu-Chek Inform II, StatStrip, Others)
- Statistical Snap of Global Point-of-Care Glucose Testing Market
- Expansion Analysis of Global Point-of-Care Glucose Testing Market
- Problems and Obstacles in Global Point-of-Care Glucose Testing Market
- Competitive Landscape in the Global Point-of-Care Glucose Testing Market
- Details on Current Investment in Global Point-of-Care Glucose Testing Market
- Competitive Analysis of Global Point-of-Care Glucose Testing Market
- Prominent Players in the Global Point-of-Care Glucose Testing Market
- SWOT Analysis of Global Point-of-Care Glucose Testing Market
- Global Point-of-Care Glucose Testing Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPERs internal database2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Point-of-Care Glucose Testing Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Point-of-Care Glucose Testing Market
7. Global Point-of-Care Glucose Testing Market, By Product, (USD Million) 2021-2034
7.1. Accu Check Aviva Meter7.2. Onetouch Verio Flex7.3. i-STAT7.4. Bayer CONTOUR Blood Glucose Monitoring System7.5. Freestyle Lite7.6. True Metrix7.7. Accu-Chek Inform II7.8. StatStrip7.9. Others
8. Global Point-of-Care Glucose Testing Market, (USD Million) 2021-2034
8.1. Global Point-of-Care Glucose Testing Market Size and Market Share
9. Global Point-of-Care Glucose Testing Market, By Region, (USD Million) 2021-2034
9.1. Asia-Pacific
9.1.1. Australia9.1.2. China9.1.3. India9.1.4. Japan9.1.5. South Korea9.1.6. Rest of Asia-Pacific
9.2. Europe
9.2.1. France9.2.2. Germany9.2.3. Italy9.2.4. Spain9.2.5. United Kingdom9.2.6. Rest of Europe
9.3. Middle East and Africa
9.3.1. Kingdom of Saudi Arabia9.3.2. United Arab Emirates9.3.3. Qatar9.3.4. South Africa9.3.5. Egypt9.3.6. Morocco9.3.7. Nigeria9.3.8. Rest of Middle-East and Africa
9.4. North America
9.4.1. Canada9.4.2. Mexico9.4.3. United States
9.5. Latin America
9.5.1. Argentina9.5.2. Brazil9.5.3. Rest of Latin America
10. Company Profile
10.1. Abbott
10.1.1. Company details10.1.2. Financial outlook10.1.3. Product summary10.1.4. Recent developments
10.2. ACON Laboratories
10.2.1. Company details10.2.2. Financial outlook10.2.3. Product summary10.2.4. Recent developments
10.3. Bayer AG/Ascensia Diabetes Care Holdings AG
10.3.1. Company details10.3.2. Financial outlook10.3.3. Product summary10.3.4. Recent developments
10.4. EKF Diagnostics
10.4.1. Company details10.4.2. Financial outlook10.4.3. Product summary10.4.4. Recent developments
10.5. F. Hoffmann-La Roche Ltd.
10.5.1. Company details10.5.2. Financial outlook10.5.3. Product summary10.5.4. Recent developments
10.6. Nipro
10.6.1. Company details10.6.2. Financial outlook10.6.3. Product summary10.6.4. Recent developments
10.7. Nova Biomedical
10.7.1. Company details10.7.2. Financial outlook10.7.3. Product summary10.7.4. Recent developments
10.8. PlatInium Equity Advisors, LLC (Lifescan, Inc.)
10.8.1. Company details10.8.2. Financial outlook10.8.3. Product summary10.8.4. Recent developments
10.9. Prodigy Diabetes Care, LLC
10.9.1. Company details10.9.2. Financial outlook10.9.3. Product summary10.9.4. Recent developments
10.10. Trividia Health, Inc.
10.10.1. Company details10.10.2. Financial outlook10.10.3. Product summary10.10.4. Recent developments
10.11. Others
11. Conclusion
12. List of Abbreviations
13. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
You can get the sample pages by clicking the link - Click Here
point-of-care-glucose-testing-market size is USD 5.36 billion from 2025 to 2034.
point-of-care-glucose-testing-market is projected to reach USD 5.36 billion by 2034, growing at a CAGR of 4.39% during the forecast period.
point-of-care-glucose-testing-market grew in Market size from 2025. The Market is expected to reach USD 5.36 billion by 2034, at a CAGR of 4.39% during the forecast period.
point-of-care-glucose-testing-market CAGR of 4.39% during the forecast period.
point-of-care-glucose-testing-market is covered By Product.
The North America is anticipated to have the highest Market share in the Point-of-Care Glucose Testing Market.
"The key players in the Market include Companies Covered Abbott, Bayer AG/Ascensia Diabetes Care Holdings AG, EKF Diagnostics, F. Hoffmann-La Roche Ltd., Nipro, Nova Biomedical, PlatInium Equity Advisors, LLC (Lifescan, Inc.), Prodigy Diabetes Care, LLC, and Trividia Health, Inc. and others.
"
The expanding geriatric population, the ability of point-of-care (POC) diagnostic tests to provide immediate results, leading to better patient care, and the growing use of electronic medical records (EMRs) are significant factors driving this market.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
